Market HighlightsDiabetes mellitus type 2 is a metabolic disorder, characterized by high blood sugar, relative lack of insulin, and insulin resistance.
The common symptoms of type 2 diabetes include constant hunger, itchy skin, weight loss, frequent urination, and others.A number of factors such as increasing technological advancements, rising prevalence of disease, related comorbidities, unmet medical needs, improvement in the regulatory framework, and increasing government assistance, are few factors propelling the growth of the global type 2 diabetes mellitus treatment market.However, the high cost of treatment, side-effects of available treatment options, and poor healthcare system in low or middle-income countries may hamper the growth of the market.It is estimated that the type 2 diabetes mellitus treatment market size is expected to grow at a CAGR 8.0% during the forecast period of 2017-2023.Regional AnalysisThe Americas dominate the type 2 diabetes mellitus treatment market owing to the presence of patient population, a well-developed technology, high healthcare expenditure, and the presence of the leading players.
For instance, The Merck Foundation provided funding of around USD 10,000,000 for the projects designed to improve diabetes care in the United States.Europe holds the second position in the type 2 diabetes mellitus treatment market.
It is expected that the government support towards research & development expenditure and amendments in reimbursement policies in the healthcare is likely to drive the European market.
As per the guidelines suggested by German maternity, every pregnant woman can undergo glucose challenge test for the early diagnosis of Gestational diabetes mellitus, and the charges for the test are completely covered by women’s health insurance.Asia Pacific is the fastest growing type 2 diabetes mellitus treatment market owing to a huge patient pool, increasing demand, and development in healthcare technology.The Middle East & Africa holds the lowest share of the global market due to low development, lack of technical knowledge, and poor medical facilities.SegmentationThe global type 2 diabetes mellitus treatment market is segmented on the basis of treatment and end user.On the basis of the treatment, the market is classified as a drug class and devices.
The devices market is further segmented into blood glucose monitoring devices and insulin delivery devices.